ArticleSkin health and disease2025

A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol.

Elizaveta Gribaleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.